Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Ischemic Heart Disease

  Free Subscription


01.08.2022

1 Am Heart J
3 Am J Cardiol
1 Am J Emerg Med
2 Ann Thorac Surg
2 Atherosclerosis
3 Cardiovasc Res
1 Catheter Cardiovasc Interv
2 Circ Cardiovasc Interv
2 Circ Heart Fail
2 Circ J
5 Circ Res
1 Circulation
1 Clin Chem
4 J Am Coll Cardiol
4 J Cardiovasc Pharmacol
2 J Mol Cell Cardiol
3 J Thorac Cardiovasc Surg
3 JAMA
1 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am Heart J

  1. SUZUKI Y, Kaneko H, Yano Y, Okada A, et al
    Glycemic status and the association of change in blood pressure with incident cardiovascular disease.
    Am Heart J. 2022 Jul 21. pii: S0002-8703(22)00148.
    PubMed         Abstract available


    Am J Cardiol

  2. MEGALY M, Sedhom R, Elbadawi A, Buda K, et al
    Trends and Outcomes of Myocardial Infarction in Patients With Previous Coronary Artery Bypass Surgery.
    Am J Cardiol. 2022 Jul 20. pii: S0002-9149(22)00631.
    PubMed         Abstract available

  3. PATOULIAS D, Papadopoulos C, Fragakis N, Karagiannis A, et al
    Meta-Analysis Evaluating the Cardiovascular Efficacy of Sodium-Glucose Co-Transporter-2 Inhibitors in Patients With Heart Failure With Reduced Ejection Fraction According to Baseline Anemia.
    Am J Cardiol. 2022 Jul 21. pii: S0002-9149(22)00661.
    PubMed        

  4. PATOULIAS D, Dimosiari A, Michailidis T, Roditis P, et al
    Meta-analysis Evaluating the Effect of Sodium-Glucose Co-Transporter-2 Inhibitors on the Risk for New-Onset Obstructive Sleep Apnea in Patients With Type 2 Diabetes Mellitus Regardless of Cardiovascular Disease at Baseline.
    Am J Cardiol. 2022 Jul 19. pii: S0002-9149(22)00660.
    PubMed        


    Am J Emerg Med

  5. AGIRBASLI M, Bolen F, Konal O, Korkmaz R, et al
    Soluble low density lipoprotein receptor-related protein-1 levels in the differential diagnosis of myopericarditis versus acute coronary syndrome.
    Am J Emerg Med. 2022;60:15-23.
    PubMed         Abstract available


    Ann Thorac Surg

  6. BALKHY HH, Nisivaco SM, Hashimoto M, Torregrossa G, et al
    Robotic Total Endoscopic Coronary Bypass in 570 Patients: Impact of Anastomotic Technique in Two Eras.
    Ann Thorac Surg. 2022;114:476-482.
    PubMed         Abstract available

  7. EDWARDS J, Binongo J, Mullin B, Wei J, et al
    Intensive Care Unit Bypass for Robotic-Assisted Single-Vessel Coronary Artery Bypass Grafting.
    Ann Thorac Surg. 2022 Jul 20. pii: S0003-4975(22)00974.
    PubMed         Abstract available


    Atherosclerosis

  8. SCHIANO C, Balbi C, Burrello J, Ruocco A, et al
    De novo DNA methylation induced by circulating extracellular vesicles from acute coronary syndrome patients.
    Atherosclerosis. 2022;354:41-52.
    PubMed         Abstract available

  9. CICERO AFG, Salvetti M
    Peripheral artery disease: A highly prevalent untreated and uncontrolled independent cardiovascular disease.
    Atherosclerosis. 2022;354:55-56.
    PubMed        


    Cardiovasc Res

  10. ZHAO T, Mallat Z
    Adapting treatments for adaptive immunity in ischaemic heart disease.
    Cardiovasc Res. 2022;118:e66-e68.
    PubMed        

  11. WEI X, Zou S, Xie Z, Wang Z, et al
    EDIL3 deficiency ameliorates adverse cardiac remodelling by neutrophil extracellular traps (NET)-mediated macrophage polarization.
    Cardiovasc Res. 2022;118:2179-2195.
    PubMed         Abstract available

  12. RIOS R, Miller RJH, Hu LH, Otaki Y, et al
    Determining a minimum set of variables for machine learning cardiovascular event prediction: results from REFINE SPECT registry.
    Cardiovasc Res. 2022;118:2152-2164.
    PubMed         Abstract available


    Catheter Cardiovasc Interv

  13. MUSTO C, Scappaticci M, Biondi-Zoccai G, De Felice F, et al
    Instantaneous wave-free ratio-guided revascularization of nonculprit lesions in STEMI patients with multivessel coronary disease: The WAVE registry.
    Catheter Cardiovasc Interv. 2022 Jul 23. doi: 10.1002/ccd.30342.
    PubMed         Abstract available


    Circ Cardiovasc Interv

  14. KUNO T, Fujisaki T, Shoji S, Sahashi Y, et al
    Comparison of Unguided De-Escalation Versus Guided Selection of Dual Antiplatelet Therapy After Acute Coronary Syndrome: A Systematic Review and Network Meta-Analysis.
    Circ Cardiovasc Interv. 2022 Jul 28:101161CIRCINTERVENTIONS122011990.
    PubMed         Abstract available

  15. JEONG YH, Obayashi Y, Song H, Kimura T, et al
    Still a Long Way to the Precision Medicine of Antiplatelet Strategy After Percutaneous Coronary Intervention.
    Circ Cardiovasc Interv. 2022 Jul 28:101161CIRCINTERVENTIONS122012261.
    PubMed        


    Circ Heart Fail

  16. BELKIN MN, Shah J, Neyestanak ME, Burkhoff D, et al
    Should We Be Using Aortic Pulsatility Index Over Cardiac Power Output in Heart Failure Cardiogenic Shock?
    Circ Heart Fail. 2022 Jun 6:101161CIRCHEARTFAILURE122009601.
    PubMed        

  17. ROSENZWEIG R, Kumar V, Gupta S, Bermeo-Blanco O, et al
    Estrogen Receptor-beta Agonists Modulate T-Lymphocyte Activation and Ameliorate Left Ventricular Remodeling During Chronic Heart Failure.
    Circ Heart Fail. 2022 Jun 22:CIRCHEARTFAILURE121008997.
    PubMed         Abstract available


    Circ J

  18. NISHI T, Kume T, Yamada R, Okamoto H, et al
    Rapid Plaque Progression Possibly Due to Intraplaque Hemorrhage in a Patient With Coronary Artery Spasm.
    Circ J. 2022;86:1309.
    PubMed        

  19. MASUNAGA N, Ogawa H, Minami K, Ishigami K, et al
    Association of Concomitant Coronary Artery Disease With Cardiovascular Events in Patients With Atrial Fibrillation- The Fushimi AF Registry.
    Circ J. 2022;86:1252-1262.
    PubMed         Abstract available


    Circ Res

  20. XUE H, Chen X, Yu C, Deng Y, et al
    Gut Microbially Produced Indole-3-Propionic Acid Inhibits Atherosclerosis by Promoting Reverse Cholesterol Transport and Its Deficiency Is Causally Related to Atherosclerotic Cardiovascular Disease.
    Circ Res. 2022 Jul 27:101161CIRCRESAHA122321253.
    PubMed         Abstract available

  21. ZHU D, Zhang Z, Zhao J, Liu D, et al
    Targeting Adiponectin Receptor 1 Phosphorylation Against Ischemic Heart Failure.
    Circ Res. 2022 May 25:101161CIRCRESAHA121319976.
    PubMed         Abstract available

  22. ROY P, Sidney J, Lindestam Arlehamn CS, Phillips E, et al
    Immunodominant MHC-II (Major Histocompatibility Complex II) Restricted Epitopes in Human Apolipoprotein B.
    Circ Res. 2022;131:258-276.
    PubMed         Abstract available

  23. DOIRON JE, Lefer DJ
    Leveraging Adipocyte-Cardiomyocyte Signaling to Treat Ischemic Heart Failure.
    Circ Res. 2022;131:165-167.
    PubMed        

  24. WAN Q, Xu C, Zhu L, Zhang Y, et al
    Targeting PDE4B (Phosphodiesterase-4 Subtype B) for Cardioprotection in Acute Myocardial Infarction via Neutrophils and Microcirculation.
    Circ Res. 2022 Jul 28:CIRCRESAHA122321365. doi: 10.1161/CIRCRESAHA.122.321365.
    PubMed         Abstract available


    Circulation

  25. KHAN SS, Page C, Wojdyla DM, Schwartz YY, et al
    Predictive Utility of a Validated Polygenic Risk Score for Long-Term Risk of Coronary Heart Disease in Young and Middle-Aged Adults.
    Circulation. 2022 Jul 26:101161CIRCULATIONAHA121058426.
    PubMed         Abstract available


    Clin Chem

  26. SAMPSON M, Wolska A, Amar M, Ueda M, et al
    Estimated Atherosclerotic Cardiovascular Disease Risk Score: An Automated Decision Aid for Statin Therapy.
    Clin Chem. 2022 Jul 28. pii: 6651094. doi: 10.1093.
    PubMed         Abstract available


    J Am Coll Cardiol

  27. MARSIT O, Clavel MA, Paquin A, Deschenes V, et al
    Effects of Cyproheptadine on Mitral Valve Remodeling and Regurgitation After Myocardial Infarction.
    J Am Coll Cardiol. 2022;80:500-510.
    PubMed         Abstract available

  28. GIUSTINO G, Colombo A, Camaj A, Yasumura K, et al
    Coronary In-Stent Restenosis: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2022;80:348-372.
    PubMed         Abstract available

  29. GOETTE A, Borof K, Breithardt G, Camm AJ, et al
    Presenting Pattern of Atrial Fibrillation and Outcomes of Early Rhythm Control Therapy.
    J Am Coll Cardiol. 2022;80:283-295.
    PubMed         Abstract available

  30. PRIEST JR
    Leveraging Machine Learning for Translational Genetics of Cardiovascular Imaging.
    J Am Coll Cardiol. 2022;80:498-499.
    PubMed        


    J Cardiovasc Pharmacol

  31. HOSSEINI SH, Talasaz AH, Alidoosti M, Tajdini M, et al
    Pre-Procedural Colchicine in Patients with Acute ST-Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention: a Randomized Controlled Trial (PodCAST-PCI).
    J Cardiovasc Pharmacol. 2022 Jun 22. pii: 00005344-990000000-00067.
    PubMed         Abstract available

  32. YANG G, Gai X, Han M, Gao F, et al
    Aberrant circulating SNHG1 serves as a biomarker to distinguish acute myocardial infarction and construction of a risk model for secondary heart failure.
    J Cardiovasc Pharmacol. 2022 Jul 11. pii: 00005344-990000000-00043.
    PubMed        

  33. VAN TASSELL BW, Wohlford GF, Del Buono MG, Damonte JI, et al
    Safety, tolerability and effects of a single subcutaneous administration of SP16-a SERPIN-like, small peptide agonist of the Low-Density Lipoprotein-like Receptor 1 -on the acute inflammatory response in patients with ST-segment elevation Myocardial I
    J Cardiovasc Pharmacol. 2022 Jul 12. pii: 00005344-990000000-00079.
    PubMed         Abstract available

  34. BAO YL, Gu LF, Du C, Wang YX, et al
    Evaluating the utility of colchicine in acute coronary syndrome: A systematic review and meta-analysis.
    J Cardiovasc Pharmacol. 2022 Jun 22. pii: 00005344-990000000-00068.
    PubMed         Abstract available


    J Mol Cell Cardiol

  35. FERRERO KM, Koch WJ
    GRK2 in cardiovascular disease and its potential as a therapeutic target.
    J Mol Cell Cardiol. 2022;172:14-23.
    PubMed         Abstract available

  36. CHENG G, Zhu D, Huang K, Caranasos TG, et al
    Minimally invasive delivery of a hydrogel-based exosome patch to prevent heart failure.
    J Mol Cell Cardiol. 2022 May 3. pii: S0022-2828(22)00085.
    PubMed         Abstract available


    J Thorac Cardiovasc Surg

  37. NAVIA D, Espinoza J, Vrancic M, Piccinini F, et al
    Bilateral internal thoracic artery grafting in elderly patients: Any benefit in survival?
    J Thorac Cardiovasc Surg. 2022;164:542-549.
    PubMed         Abstract available

  38. LOCKER C
    Commentary: Bilateral internal thoracic artery grafting in elderly patients? Elephant on a slippery slope.
    J Thorac Cardiovasc Surg. 2022;164:554-556.
    PubMed        

  39. NAVIA D, Espinoza J, Vrancic M, Piccinini F, et al
    Bilateral internal thoracic artery grafting in elderly patients makes sense indeed.
    J Thorac Cardiovasc Surg. 2022;164:e88.
    PubMed        


    JAMA

  40. SHUFELT CL, Mora S, Manson JE
    Aspirin for the Primary Prevention of Atherosclerotic Cardiovascular Disease in Women.
    JAMA. 2022 Jul 25. pii: 2794800. doi: 10.1001/jama.2022.11951.
    PubMed        

  41. MANGIONE CM, Barry MJ, Nicholson WK, Cabana M, et al
    Behavioral Counseling Interventions to Promote a Healthy Diet and Physical Activity for Cardiovascular Disease Prevention in Adults Without Cardiovascular Disease Risk Factors: US Preventive Services Task Force Recommendation Statement.
    JAMA. 2022;328:367-374.
    PubMed         Abstract available

  42. PATNODE CD, Redmond N, Iacocca MO, Henninger M, et al
    Behavioral Counseling Interventions to Promote a Healthy Diet and Physical Activity for Cardiovascular Disease Prevention in Adults Without Known Cardiovascular Disease Risk Factors: Updated Evidence Report and Systematic Review for the US Preventive
    JAMA. 2022;328:375-388.
    PubMed         Abstract available


    PLoS One

  43. BINTI NN, Ferdausi N, Anik MEK, Islam LN, et al
    Association of albumin, fibrinogen, and modified proteins with acute coronary syndrome.
    PLoS One. 2022;17:e0271882.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Ischemic Heart Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: